Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Mileshkin

Showing results (11-20 of 174) with videos related to

Pageof 18
Sort By:
Leukemia & Lymphoma|February 28, 2007
An analysis of clinical trials assessing the efficacy and safety of single-agent thalidomide in patients with relapsed or refractory multiple myelomaH Miles Prince, Brad Schenkel, Linda Mileshkin
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyondHelen J Mackay, Lari Wenzel, Linda Mileshkin
Asia-Pacific Journal of Clinical Oncology|March 3, 2018
Outcomes of Australian patients receiving non-funded anti-PD-1 immune checkpoint inhibitors for non-melanoma cancersCrescens Tiu, Annie Wong, Alan Herschtal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2023
<i>CCNE1</i> Amplification as a Therapeutic TargetGeorge Au-Yeung, Linda Mileshkin, David D L Bowtell
American Journal of Clinical Oncology|December 13, 2002
CNS listeriosis confused with leptomeningeal carcinomatosis in a patient with a malignant insulinomaLinda Mileshkin, Michael Michael, Mary O'Reilly, et al.
Psycho-Oncology|February 7, 2020
Understanding and information needs of cancer patients regarding treatment-focused genomic testing: A systematic reviewKamil Wolyniec, Jessica Sharp, Smaro Lazarakis, et al.
Asia-Pacific Journal of Clinical Oncology|November 28, 2018
Practical considerations for clinicians for transitioning patients on maintenance therapy with olaparib capsules to the tablet formulation of olaparibMichael Friedlander, Catherine Shannon, Jeffrey Goh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 15, 2011
Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapyKailash Narayan, Pearly Khaw, David Bernshaw, et al.
British Journal of Haematology|November 18, 2003
Serum MUC-1 as a marker of disease status in multiple myeloma patients receiving thalidomideLinda Mileshkin, H M Prince, J F Seymour, et al.
Journal of Gynecologic Oncology|August 22, 2014
The survival outcome and patterns of failure in node positive endometrial cancer patients treated with surgery and adjuvant radiotherapy with curative intentChrishanthi Rajasooriyar, David Bernshaw, Srinivas Kondalsamy-Chennakesavan, et al.
Pageof 18

Showing results (11-20 of 174) with videos related to

Sort By:
Pageof 18
Leukemia & Lymphoma|February 28, 2007
An analysis of clinical trials assessing the efficacy and safety of single-agent thalidomide in patients with relapsed or refractory multiple myelomaH Miles Prince, Brad Schenkel, Linda Mileshkin
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyondHelen J Mackay, Lari Wenzel, Linda Mileshkin
Asia-Pacific Journal of Clinical Oncology|March 3, 2018
Outcomes of Australian patients receiving non-funded anti-PD-1 immune checkpoint inhibitors for non-melanoma cancersCrescens Tiu, Annie Wong, Alan Herschtal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2023
<i>CCNE1</i> Amplification as a Therapeutic TargetGeorge Au-Yeung, Linda Mileshkin, David D L Bowtell
American Journal of Clinical Oncology|December 13, 2002
CNS listeriosis confused with leptomeningeal carcinomatosis in a patient with a malignant insulinomaLinda Mileshkin, Michael Michael, Mary O'Reilly, et al.
Psycho-Oncology|February 7, 2020
Understanding and information needs of cancer patients regarding treatment-focused genomic testing: A systematic reviewKamil Wolyniec, Jessica Sharp, Smaro Lazarakis, et al.
Asia-Pacific Journal of Clinical Oncology|November 28, 2018
Practical considerations for clinicians for transitioning patients on maintenance therapy with olaparib capsules to the tablet formulation of olaparibMichael Friedlander, Catherine Shannon, Jeffrey Goh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 15, 2011
Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapyKailash Narayan, Pearly Khaw, David Bernshaw, et al.
British Journal of Haematology|November 18, 2003
Serum MUC-1 as a marker of disease status in multiple myeloma patients receiving thalidomideLinda Mileshkin, H M Prince, J F Seymour, et al.
Journal of Gynecologic Oncology|August 22, 2014
The survival outcome and patterns of failure in node positive endometrial cancer patients treated with surgery and adjuvant radiotherapy with curative intentChrishanthi Rajasooriyar, David Bernshaw, Srinivas Kondalsamy-Chennakesavan, et al.
Pageof 18